Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens

被引:133
作者
Iwasaki, Masashi [3 ]
Tanaka, Yoshimasa [1 ,2 ]
Kobayashi, Hirohito [4 ]
Murata-Hirai, Kaoru
Miyabe, Hideto
Sugie, Tomoharu [5 ]
Toi, Masakazu [5 ]
Minato, Nagahiro [1 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Kyoto, Japan
[4] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
关键词
gamma delta T cells; Phosphoantigen; PD-1; PD-L1; Tumor; NONPEPTIDE ANTIGENS; DILATED CARDIOMYOPATHY; MEDIATED RECOGNITION; ZOLEDRONIC ACID; TUMOR-CELLS; IN-VIVO; IMMUNOTHERAPY; RECEPTOR; B7-H1; PATHWAY;
D O I
10.1002/eji.201040959
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed cell death-1 (PD-1) is an inhibitory receptor and plays an important role in the regulation of alpha beta T cells. Little is known, however, about the role of PD-1 in gamma delta T cells. In this study, we investigated the expression and function of PD-1 in human gamma delta T cells. Expression of PD-1 was rapidly induced in primary gamma delta T cells following antigenic stimulation, and the PD-1(+) gamma delta T cells produced IL-2. When PD-1(+) gamma delta T cells were stimulated with Daudi cells with and without programmed cell death ligand-1 (PD-L1) expression, the levels of IFN-gamma production and cytotoxicity in response to PD-L1(+) Daudi cells were diminished compared to the levels seen in response to PD-L1(-) Daudi cells. The attenuated effector functions were reversed by anti-PD-L1 mAb. When PD-L1(+) gamma delta T cells were challenged by PD-L1(+) tumors pretreated with zoledronate (Zol), which induced gamma delta TCR-mediated signaling, the resulting reduction in cytokine production was only slight to moderate compared to the reduction seen when PD-L1(+) gamma delta T cells were challenged by PD-L1(-) tumors. In addition, cytotoxic activity of PD-L1(+) gamma delta T cells against Zol-treated PD-L1(+) tumors was comparable to that against Zol-treated PD-L1(-) tumors. These results suggest that TCR triggering may partially overcome the inhibitory effect of PD-1 in gamma delta T cells.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 50 条
[31]   Targeting of tumor cells for human γδ T cells by nonpeptide antigens [J].
Kato, Y ;
Tanaka, Y ;
Miyagawa, F ;
Yamashita, S ;
Minato, N .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5092-5098
[32]   Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study [J].
Kobayashi, Hirohito ;
Tanaka, Yoshimasa ;
Yagi, Junji ;
Osaka, Yukinari ;
Nakazawa, Hayakazu ;
Uchiyama, Takehiko ;
Minato, Nagahiro ;
Toma, Hiroshi .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (04) :469-476
[33]  
Kobayashi H, 2010, ANTICANCER RES, V30, P575
[34]   γ/δ T-cell stimulation by pamidronate [J].
Kunzmann, V ;
Bauer, E ;
Wilhelm, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (09) :737-738
[35]  
Kunzmann V, 2000, BLOOD, V96, P384
[36]   PD-L2 is a second ligand for PD-I and inhibits T cell activation [J].
Latchman, Y ;
Wood, CR ;
Chernova, T ;
Chaudhary, D ;
Borde, M ;
Chernova, I ;
Iwai, Y ;
Long, AJ ;
Brown, JA ;
Nunes, R ;
Greenfield, EA ;
Bourque, K ;
Boussiotis, VA ;
Carter, LL ;
Carreno, BM ;
Malenkovich, N ;
Nishimura, H ;
Okazaki, T ;
Honjo, T ;
Sharpe, AH ;
Freeman, GJ .
NATURE IMMUNOLOGY, 2001, 2 (03) :261-268
[37]   Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2 [J].
Lazar-Molnar, Eszter ;
Yan, Qingrong ;
Cao, Erhu ;
Ramagopal, Udupi ;
Nathenson, Stanley G. ;
Almo, Steven C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10483-10488
[38]   The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors [J].
Lin, David Yin-Wei ;
Tanaka, Yoshimasa ;
Iwasaki, Masashi ;
Gittis, Apostolos G. ;
Su, Hua-Poo ;
Mikami, Bunzo ;
Okazaki, Taku ;
Honjo, Tasuku ;
Minato, Nagahiro ;
Garboczi, David N. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) :3011-3016
[39]   Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells:: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens [J].
Morita, Craig T. ;
Jin, Chenggang ;
Sarikonda, Ghanashyam ;
Wang, Hong .
IMMUNOLOGICAL REVIEWS, 2007, 215 :59-76
[40]   Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice [J].
Nishimura, H ;
Okazaki, T ;
Tanaka, Y ;
Nakatani, K ;
Hara, M ;
Matsumori, A ;
Sasayama, S ;
Mizoguchi, A ;
Hiai, H ;
Minato, N ;
Honjo, T .
SCIENCE, 2001, 291 (5502) :319-322